ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 151 filers reported holding ARGENX SE in Q4 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,705,000 | +657.8% | 5,800 | +480.0% | 0.46% | +255.0% |
| Q2 2020 | $225,000 | -78.9% | 1,000 | -84.9% | 0.13% | -60.3% |
| Q4 2019 | $1,064,000 | +70.8% | 6,631 | +21.1% | 0.33% | +73.7% |
| Q3 2019 | $623,000 | +66.6% | 5,475 | +82.5% | 0.19% | +48.4% |
| Q1 2019 | $374,000 | -88.5% | 3,000 | -93.0% | 0.13% | -83.2% |
| Q3 2018 | $3,261,000 | – | 43,000 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |